Stem cell banking, built for Right to Try.
BankRTT is a program for licensed physicians. Bank a patient's own adipose-derived stem cells, then request an investigational stem cell product in an FDA-authorized Phase 2 trial through the federal Right to Try Act.
Patients: ask your doctor to apply. Already enrolled? Log in at CellBankPortal.com
Preclinical
Lab and animal studies
Phase 1
First safety testing in people
CompletedPhase 3
Large confirmatory trials
FDA approval
Sold on the general market
Not yet approvedWhat the Right to Try Act makes possible
Access to investigational stem cell treatment in the United States, held to FDA and state medical board standards.
Welcome to BankRTT. Our goal is to make sure you understand the federal Right to Try legislation and how it lets patients and physicians access stem cell treatments that would otherwise not be available in the United States, or in most of the world.
Although similar treatments may be offered elsewhere, they are not held to the same safety standards that the U.S. FDA and individual state medical boards impose on physicians, including Medical Doctors (MDs) and Doctors of Osteopathic Medicine (DOs).
To qualify for Right to Try, an FDA Investigational New Drug (IND) must have completed Phase 1 and be at Phase 2 or higher. This high standard means the product has already undergone significant scrutiny. Many stem cell products and their byproducts, such as exosomes, have not undergone this level of scrutiny or have failed to advance to an FDA-cleared IND. Those products are not approved for use in the general market.
How a Right to Try product compares
| Criteria | BankRTT under Right to Try | Unapproved clinic and exosome products |
|---|---|---|
| FDA status | Active IND, Phase 1 completed, in Phase 2 | Often no IND, or failed to advance |
| Human safety data | From a completed Phase 1 clinical trial | Limited or none |
| Who treats | Licensed U.S. MD or DO, accountable to a state medical board | Varies, often outside U.S. oversight |
| Patient consent | Written informed consent, required by federal law | Not standardized |
| Product pricing | Cost recovery only, no markup | Set by the seller |
How the program works
Each patient goes through the same five steps, led by their physician. Access to the investigational product always depends on the manufacturer's review and approval.
Apply and train
Submit your physician application and complete the 3-hour Continuing Education program.
Evaluate the patient
Confirm eligibility and record your clinical evaluation.
Sign informed consent
Review risks, benefits and alternatives. You and your patient both sign.
Bank the cells
Collect the patient's adipose (fat) tissue. Their stem cells are processed and stored.
Request access and treat
The manufacturer reviews each request. Treatment and follow-up stay under your care.
Patient eligibility evaluation
The patient must consult with their doctor, and a formal evaluation determines whether they qualify. The patient must have a life-threatening disease or condition.
- Is there another clinical trial available for the patient's condition, and is it feasible for the patient to enroll?
- Has the patient explored other approved treatment options, or have those options been thoroughly explained?
- Are there specific reasons, such as potential side effects, why the patient is not using an approved product?
- Does the patient understand the risks of this Right to Try experimental product?
This product is not FDA-approved. Its safety and effectiveness have not been fully established, and no benefit is guaranteed. Patients can stop at any time without penalty.
Physician requirements
Does the doctor understand their responsibilities and educational requirements under Right to Try? We require every physician to complete a 3-hour Continuing Education program that explains the program in detail.
- Licensed MD or DO in good standing
- 3-hour CME program completed
- Eligibility evaluated and recorded
- Written informed consent signed
Apply to the program
The Stem Cell Banking & Treatment RTT program is open to licensed MDs and DOs in good standing. To apply, email us the details listed here.
What happens next
We review every application and reply by email with next steps and access to the 3-hour Continuing Education program.
Email your application to
support@bankrtt.com
Include the following
- Full name and credentialMD or DO
- SpecialtyFor example, gastroenterology
- NPI number10 digits
- Medical license numberAnd the state that issued it
- Work email and phoneWhere we can reach you
- Practice or clinic nameOptional
- Conditions you plan to treatOptional
- CE commitmentConfirm you will complete the 3-hour CME program before treating patients
Opens your email app with these details ready to fill in.
PrivacyDo not include patient names or health information in your email.
Already in the program?
Log in to the cell bank portal. To get an account, email support@bankrtt.com.
Questions physicians ask
Can't find your answer? Email support@bankrtt.com.
What is the federal Right to Try Act?
The federal Right to Try Act (Public Law 115-176, signed May 30, 2018) lets patients with a life-threatening disease or condition access eligible investigational drugs outside of a clinical trial. The patient's physician certifies eligibility, the patient gives written informed consent, and the manufacturer must agree to provide the product.
Which investigational products qualify?
A product qualifies when its Phase 1 clinical trial is complete, it is not FDA-approved for any use, it is the subject of an FDA application or an active Investigational New Drug (IND) application, and its development has not been stopped or placed on clinical hold.
Is the stem cell product FDA-approved?
No. It is an investigational adipose-derived stem cell product that is the subject of an active FDA-authorized Phase 2 clinical trial (NCT07010926). Its safety and effectiveness have not been fully established.
Who can apply?
Licensed MDs and DOs in good standing. To apply, email support@bankrtt.com with your name, credential, specialty, NPI number, medical license number and state, and contact details. Patients cannot enroll directly. If you are a patient, ask your physician to apply.
What is stem cell banking?
Stem cell banking means collecting a patient's own cells, in this program from adipose (fat) tissue, then processing and storing them so they are available for future treatment.
How much does it cost the patient?
The investigational product is charged at cost recovery with no markup. The patient cannot be charged more than the direct cost paid by the treating physician or facility.
Standard medical costs, such as physician fees, tests and follow-up care, are separate. Insurance may not cover them because the treatment is investigational.
Is training required?
Yes. Every physician completes a 3-hour Continuing Education program that explains the Right to Try pathway and their responsibilities in detail.
Can a patient stop treatment?
Yes. Participation is voluntary. A patient can stop receiving the investigational product at any time, for any reason, without penalty.
How do I get a portal account?
Email support@bankrtt.com to request access. Once your account is set up, log in at CellBankPortal.com.